Skip to main content

Asthma

British Thoracic Society Clinical Statement on occupational asthma

Article

This British Thoracic Society (BTS) Clinical Statement addresses occupational asthma and includes key clinical practice points. In an era in which medical practice is increasingly determined by evidence-based guidelines, it must be acknowledged from the outset that there is little or no published evidence for some of the areas covered in this statement; thus, much of the advice is based on expert opinion and accumulated clinical experience.

Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016

Article

Asthma is the most common respiratory disorder in the UK, yet we have incomplete knowledge on the prevalence of current disease, treatment and exacerbations.

We used UK electronic healthcare records, 2006–2016, to estimate the prevalence of current asthma by year, sex and age (<5, 5–11, 12–17, 18–24, 25–54 and ≥55 years), and the proportion prescribed inhaled corticosteroids (ICS) and additional asthma therapy, treated for exacerbations and other asthma care markers.

Exacerbation patterns in adults with asthma in England. A population-based study

Article

Rationale: Asthma is heterogeneous and knowledge on exacerbation patterns is lacking. Previous studies have had a relatively short follow-up or focused on severe disease.

Objectives: To describe exacerbation patterns over a prolonged follow-up in a population that includes patients of all disease severity.

Follow-up survey of patients with occupational asthma

Article
Using a postal questionnaire, we surveyed all patients attending our specialist occupational lung disease clinic 1 year after having received a diagnosis of OA due to a sensitizer (n = 125). We enquired about their current health and employment status and impact of their diagnosis on various aspects of their life. Additional information was collected by review of clinical records.